Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
New shares were offered at a premium and mostly taken by an external investor in the unusual capital increase -
PE firm Quadria is looking to trim its stake in the Indian biopharmaceutical company
-
-
Smaller, privately owned companies are becoming a key part of the local IPO market
-
Government interventions staved off pandemic-related defaults, though macro headwinds are causing uncertainty
-
Verona Pharma and Borr Drilling raise capital at opportune moment
